STAQ Pharma, Inc. — Form D/A
STAQ Pharma, Inc. of DENVER, CO, a company, filed a Form D amendment with the SEC on 2020-04-07. The offering totals $9.0M, of which $7.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-04-07
- Form: D/A
- Accession: 0001796430-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.0M
- Amount sold: $7.8M
- Remaining: $1.2M
- Minimum investment: $5K
- Investors: 20
- Date of first sale: 2019-04-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-338821
Issuer
- Name: STAQ Pharma, Inc.
- CIK: 0001722397
- Entity type: Corporation
- Jurisdiction: COLORADO
- Address: 14135 E. 42ND AVE., DENVER, CO, 80239
- Phone: 720-961-2720
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Scott M Hawig | Director | Denver, CO |
| Mark M Spiecker | Director | Denver, CO |
| Mark M Spiecker | Executive Officer | Denver, CO |
| Carol M Lewis | Director | Denver, CO |
| Chet M Kaczor | Director | Denver, CO |
| Dan M Seff | Director | Denver, CO |
| Brad M Hauert | Director | Denver, CO |
| Joseph W Bagan | Director | Denver, CO |
| Joseph W Bagan | Executive Officer | Denver, CO |
| Jeffrey L Hval | Director | Denver, CO |
| Jeffrey L Hval | Executive Officer | Denver, CO |
| Paul M Jenny | Director | Denver, CO |
| Abram M Gordon | Director | Denver, CO |
| Jerrod M Milton | Director | Denver, CO |
| Steven M Summer | Director | Denver, CO |
| DONNA M LYNNE | Director | DENVER, CO |
| STEPHEN M DAVIS | Director | DENVER, CO |
| Mark W Spiecker | Director | Englewood, CO |
| Mark W Spiecker | Executive Officer | Englewood, CO |
| Jeffrey W Hval | Director | Englewood, CO |
| Jeffrey W Hval | Executive Officer | Englewood, CO |
| Jeffrey W Hval | Promoter | Englewood, CO |
Other filings by this issuer (10)
More